EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation

Ziqi Zhu, Xinyi Xie, Weijia Meng, Kenuo Fang, Jiahui Deng, Yusi Yan, Jundong Wei, Lisha Zhou

Marine Drugs · 10.11.2026 · 24 (11) · 403

DOI: 10.3390/md24110403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 10.11.2026. Verfasst von Ziqi Zhu und 7 weiteren Autor:innen. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National College Students’ Innovative Entrepreneurial Training Plan Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer continues to impose a major global health burden. Conventional therapies often show poor selectivity, off-target toxicity, and drug resistance, creating an urgent need for new agents. The marine environment covers roughly 71% of Earth’s surface and has fostered metabolites of unparalleled chemical diversity, making the ocean a vital source for anticancer drug discovery. This review critically examines the published literature on six representative marine-derived agents—cytarabine, trabectedin, eribulin, brentuximab vedotin, carrageenan, and Aspergillus fumigatus alkaloids. We compare their biological sources, anti-tumor spectra, molecular targets, and oncogenic pathways, and we analyze the structure—activity relationships and the total, semi-, and engineered synthesis routes that underpin their optimization. We also appraise the major barriers to clinical translation—sustainable supply, mechanistic ambiguity, and suboptimal druggability—alongside emerging solutions based on synthetic biology, multi-omics, artificial intelligence, and advanced formulation. Marine-derived agents therefore represent a chemically distinctive and mechanistically diverse reservoir for targeted cancer therapy. Realizing this potential will require structure—activity-guided optimization, secure synthetic or engineered supply, and biomarker-informed combination strategies that still await prospective validation.

Förderung

  • National Natural Science Foundation of China
  • National College Students’ Innovative Entrepreneurial Training Plan Program

Zitieren

APA

Zhu, Z., Xie, X., Meng, W., Fang, K., Deng, J., Yan, Y., Wei, J., & Zhou, L. (2026). Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation. Marine Drugs, 24(11), 403. https://doi.org/10.3390/md24110403

Vancouver

Zhu Z, Xie X, Meng W, Fang K, Deng J, Yan Y, et al. Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation. Marine Drugs. 2026;24(11):403. doi:10.3390/md24110403

BibTeX
@article{Zhu2026,
  author = {Zhu, Ziqi and Xie, Xinyi and Meng, Weijia and Fang, Kenuo and Deng, Jiahui and Yan, Yusi and Wei, Jundong and Zhou, Lisha},
  title = {Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {11},
  pages = {403},
  doi = {10.3390/md24110403}
}
Kostenlos starten →